Promoting and facilitating strategies to improve cardiovascular health worldwide

Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



1 in 5 high CV-risk patients may experience an event after noncardiac surgery

Posted on October 19, 2020

Among high-CV risk patients who underwent noncardiac surgery, up to one-fifth could experience a major adverse CV event within 1 year of... more

Transcatheter device may benefit patients with HF waiting for transplantation

Posted on October 19, 2020

A transcatheter device was a safe and effective bridge strategy to heart transplantation in patients with end-stage HF, with 23.5% removed from... more

Inhaled formulation of vardenafil for as-needed use shows promise in PAH

Posted on October 18, 2020

An inhaled formulation of the PDE5 inhibitor vardenafil, in development for as-needed use for episodic symptoms of pulmonary arterial hypertension, yielded improvements... more

No sign of paclitaxel-related mortality risk in VOYAGER PAD cohort

Posted on October 18, 2020

At 3.5 years after lower-extremity revascularization, there was no difference in mortality in the VOYAGER PAD cohort between patients with peripheral artery... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  •  Hector Ventura


    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  •  Jack Tan


    Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis (more…) more

  •  Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  •  Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more